Search hospitals > Nebraska > Bellevue
Nebraska Medicine-Bellevue
Claim this profileBellevue, Nebraska 68123
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Tumors
73 reported clinical trials
20 medical researchers
Summary
Nebraska Medicine-Bellevue is a medical facility located in Bellevue, Nebraska. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Tumors and other specialties. Nebraska Medicine-Bellevue is involved with conducting 73 clinical trials across 188 conditions. There are 20 research doctors associated with this hospital, such as Matthew Lunning, DO, Apar K. Ganti, Jairam Krishnamurthy, MD, and Vijaya R. Bhatt.Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
Global LeaderHER2 positive
ER positive
HER2 negative
Top PIs
Matthew Lunning, DOUniversity of Nebraska Medical Center3 years of reported clinical research
Studies Lymphoma
Studies B-Cell Lymphoma
12 reported clinical trials
37 drugs studied
Apar K. GantiUniversity of Nebraska Medical Center4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
8 reported clinical trials
15 drugs studied
Jairam Krishnamurthy, MDUniversity of Nebraska Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
22 drugs studied
Vijaya R. BhattUniversity of Nebraska Medical Center7 years of reported clinical research
Studies Leukemia
Studies Myeloid Leukemia
7 reported clinical trials
15 drugs studied
Clinical Trials running at Nebraska Medicine-Bellevue
Breast Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Prostate Cancer
Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Esophageal Cancer
Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Nebraska Medicine-Bellevue?
Nebraska Medicine-Bellevue is a medical facility located in Bellevue, Nebraska. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Tumors and other specialties. Nebraska Medicine-Bellevue is involved with conducting 73 clinical trials across 188 conditions. There are 20 research doctors associated with this hospital, such as Matthew Lunning, DO, Apar K. Ganti, Jairam Krishnamurthy, MD, and Vijaya R. Bhatt.